Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 6GENZYME CORP
02 8ALNYLAM PHARMS INC
01 18106022
02 18828956
03 29127274
04 19133461
05 29376680
06 19631193
07 110119143
08 110125364
09 110131907
10 111028392
11 211091759
01 11Y
02 3Blank
01 11Y
02 3Blank
01 12028-08-24
02 12028-12-04
03 12029-12-12
04 42033-03-15
05 22033-03-22
06 12033-11-30
07 22034-10-03
08 22036-12-07
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2036-12-07
US Patent Number : 11091759
Drug Substance Claim :
Drug Product Claim :
Application Number : 219019
Patent Use Code : U-4165
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2036-12-07
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2036-12-07
US Patent Number : 11091759
Drug Substance Claim :
Drug Product Claim :
Application Number : 219019
Patent Use Code : U-4165
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2036-12-07
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2033-03-15
US Patent Number : 9376680
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 219019
Patent Use Code : U-4165
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2033-03-15
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2033-03-15
US Patent Number : 9376680
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 219019
Patent Use Code : U-4165
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2033-03-15
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2033-03-22
US Patent Number : 9127274
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 219019
Patent Use Code : U-4165
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2033-03-22
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2033-03-22
US Patent Number : 9127274
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 219019
Patent Use Code : U-4165
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2033-03-22
Patent Expiration Date : 2033-03-15
US Patent Number : 9631193
Drug Substance Claim :
Drug Product Claim :
Application Number : 212194
Patent Use Code : U-2672
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2033-03-15
Patent Expiration Date : 2028-08-24
US Patent Number : 10131907
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 212194
Patent Use Code : U-2672
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2028-08-24
Patent Expiration Date : 2033-03-15
US Patent Number : 10125364
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 212194
Patent Use Code : U-2672
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2033-03-15
Patent Expiration Date : 2029-12-12
US Patent Number : 8106022
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 212194
Patent Use Code : U-2672
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-12-12
